A Win for SkinITScienceScience / Health New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent adminOctober 25, 2026 1 Views The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
